FDA Approves CardioQ-EDM+

On 23 October 2013, the US Food and Drug Administration (FDA) approved the launch of the CardioQ-EDM+ monitor in the American market place.  The EDM+ has already generated considerable interest…

US Authorities Publish EDM Payment

In April 2013, the EDM monitor became the first procedure to be separately billable by anesthesiologists in the USA for over a decade.  Following the establishment of this procedure specific…

French Guidelines (SFAR) make ODM standard of Care in France

Today, the Société Française d’Anesthésie et de Réanimation (SFAR) guidelines were published in France and make it clear that ODM-guided fluid management should be used in all high risk surgery…

Terminus Road | Chichester | PO19 8TX | United Kingdom

  • Enquiries: +44 1243 774837
  • Email: marketing@deltexmedical.com
  • Deltex App:


Registered in England & Wales Company No: 1691369